Is NTGR or CAMP more profitable?

NETGEAR has a net margin of -3.58% compared to CAMP4 Therapeutics' net margin of -2,193.72%. NETGEAR's return on equity of -2.71% beat CAMP4 Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets NETGEAR -3.58% -2.71% -1.66% CAMP4 Therapeutics -2,193.72% -194.74% -95.64%

Does the media favor NTGR or CAMP?

In the previous week, NETGEAR had 3 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 7 mentions for NETGEAR and 4 mentions for CAMP4 Therapeutics. CAMP4 Therapeutics' average media sentiment score of 0.15 beat NETGEAR's score of -0.24 indicating that CAMP4 Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NETGEAR 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CAMP4 Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer CAMP or RBBN?

In the previous week, Ribbon Communications had 3 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 7 mentions for Ribbon Communications and 4 mentions for CAMP4 Therapeutics. Ribbon Communications' average media sentiment score of 0.52 beat CAMP4 Therapeutics' score of 0.15 indicating that Ribbon Communications is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CAMP4 Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Ribbon Communications 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor AVNW or CAMP?

In the previous week, Aviat Networks had 1 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 5 mentions for Aviat Networks and 4 mentions for CAMP4 Therapeutics. Aviat Networks' average media sentiment score of 0.21 beat CAMP4 Therapeutics' score of 0.15 indicating that Aviat Networks is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aviat Networks 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CAMP4 Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAMP or CMTL?

In the previous week, CAMP4 Therapeutics had 2 more articles in the media than Comtech Telecommunications. MarketBeat recorded 4 mentions for CAMP4 Therapeutics and 2 mentions for Comtech Telecommunications. Comtech Telecommunications' average media sentiment score of 1.43 beat CAMP4 Therapeutics' score of 0.15 indicating that Comtech Telecommunications is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CAMP4 Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Comtech Telecommunications 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer KVHI or CAMP?

CAMP4 Therapeutics has a consensus target price of $8.60, suggesting a potential upside of 114.46%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than KVH Industries. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KVH Industries 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CAMP4 Therapeutics 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57

Does the media prefer KVHI or CAMP?

In the previous week, CAMP4 Therapeutics had 1 more articles in the media than KVH Industries. MarketBeat recorded 4 mentions for CAMP4 Therapeutics and 3 mentions for KVH Industries. KVH Industries' average media sentiment score of 0.87 beat CAMP4 Therapeutics' score of 0.15 indicating that KVH Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KVH Industries 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CAMP4 Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

CAMP4 Therapeutics (CAMP) Competitors

$4.08 -0.01 (-0.37%)

As of 04:00 PM Eastern

Compare

CAMP vs. NTGR, RBBN, AVNW, CMTL, and KVHI

Should you buy CAMP4 Therapeutics stock or one of its competitors? MarketBeat compares CAMP4 Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CAMP4 Therapeutics include NETGEAR (NTGR), Ribbon Communications (RBBN), Aviat Networks (AVNW), Comtech Telecommunications (CMTL), and KVH Industries (KVHI). These companies are all part of the "communications equipment" industry.

How does CAMP4 Therapeutics compare to NETGEAR?

NETGEAR (NASDAQ:NTGR) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

NETGEAR has higher revenue and earnings than CAMP4 Therapeutics. NETGEAR is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NETGEAR	$699.62M	0.93	-$17.92M	-$0.88	N/A
CAMP4 Therapeutics	$3.50M	59.50	-$80.40M	-$2.36	N/A

NETGEAR currently has a consensus price target of $36.00, suggesting a potential upside of 49.07%. CAMP4 Therapeutics has a consensus price target of $8.60, suggesting a potential upside of 114.46%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe CAMP4 Therapeutics is more favorable than NETGEAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NETGEAR	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
CAMP4 Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

NETGEAR has a net margin of -3.58% compared to CAMP4 Therapeutics' net margin of -2,193.72%. NETGEAR's return on equity of -2.71% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NETGEAR	-3.58%	-2.71%	-1.66%
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%

83.0% of NETGEAR shares are held by institutional investors. 3.1% of NETGEAR shares are held by insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NETGEAR has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.08, suggesting that its stock price is 92% less volatile than the broader market.

In the previous week, NETGEAR had 3 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 7 mentions for NETGEAR and 4 mentions for CAMP4 Therapeutics. CAMP4 Therapeutics' average media sentiment score of 0.15 beat NETGEAR's score of -0.24 indicating that CAMP4 Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NETGEAR	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CAMP4 Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

NETGEAR beats CAMP4 Therapeutics on 9 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Ribbon Communications?

CAMP4 Therapeutics (NASDAQ:CAMP) and Ribbon Communications (NASDAQ:RBBN) are both small-cap communications equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Ribbon Communications has higher revenue and earnings than CAMP4 Therapeutics. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Ribbon Communications, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CAMP4 Therapeutics	$3.50M	59.50	-$80.40M	-$2.36	N/A
Ribbon Communications	$844.56M	0.55	$39.64M	$0.17	15.65

CAMP4 Therapeutics has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market. Comparatively, Ribbon Communications has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

In the previous week, Ribbon Communications had 3 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 7 mentions for Ribbon Communications and 4 mentions for CAMP4 Therapeutics. Ribbon Communications' average media sentiment score of 0.52 beat CAMP4 Therapeutics' score of 0.15 indicating that Ribbon Communications is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CAMP4 Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ribbon Communications	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

CAMP4 Therapeutics currently has a consensus target price of $8.60, suggesting a potential upside of 114.46%. Ribbon Communications has a consensus target price of $3.58, suggesting a potential upside of 34.59%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe CAMP4 Therapeutics is more favorable than Ribbon Communications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CAMP4 Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Ribbon Communications	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

70.9% of Ribbon Communications shares are held by institutional investors. 21.7% of CAMP4 Therapeutics shares are held by company insiders. Comparatively, 4.0% of Ribbon Communications shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Ribbon Communications has a net margin of 3.80% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Ribbon Communications' return on equity of 24.14% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%
Ribbon Communications	3.80%	24.14%	8.35%

Summary

Ribbon Communications beats CAMP4 Therapeutics on 11 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Aviat Networks?

Aviat Networks (NASDAQ:AVNW) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Aviat Networks has higher revenue and earnings than CAMP4 Therapeutics. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Aviat Networks, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aviat Networks	$434.61M	0.56	$1.34M	$0.69	27.23
CAMP4 Therapeutics	$3.50M	59.50	-$80.40M	-$2.36	N/A

Aviat Networks has a net margin of 2.08% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Aviat Networks' return on equity of 6.89% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aviat Networks	2.08%	6.89%	2.89%
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%

78.6% of Aviat Networks shares are owned by institutional investors. 5.3% of Aviat Networks shares are owned by company insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Aviat Networks currently has a consensus price target of $30.00, indicating a potential upside of 59.66%. CAMP4 Therapeutics has a consensus price target of $8.60, indicating a potential upside of 114.46%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than Aviat Networks.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aviat Networks	2 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29
CAMP4 Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, Aviat Networks had 1 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 5 mentions for Aviat Networks and 4 mentions for CAMP4 Therapeutics. Aviat Networks' average media sentiment score of 0.21 beat CAMP4 Therapeutics' score of 0.15 indicating that Aviat Networks is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aviat Networks	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CAMP4 Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aviat Networks has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.08, suggesting that its share price is 92% less volatile than the broader market.

Summary

Aviat Networks beats CAMP4 Therapeutics on 11 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

CAMP4 Therapeutics (NASDAQ:CAMP) and Comtech Telecommunications (NASDAQ:CMTL) are both small-cap communications equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

CAMP4 Therapeutics has higher earnings, but lower revenue than Comtech Telecommunications. Comtech Telecommunications is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CAMP4 Therapeutics	$3.50M	59.50	-$80.40M	-$2.36	N/A
Comtech Telecommunications	$499.53M	0.25	-$155.30M	-$2.23	N/A

Comtech Telecommunications has a net margin of 2.60% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Comtech Telecommunications' return on equity of 50.25% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%
Comtech Telecommunications	2.60%	50.25%	6.36%

CAMP4 Therapeutics presently has a consensus price target of $8.60, indicating a potential upside of 114.46%. Comtech Telecommunications has a consensus price target of $6.00, indicating a potential upside of 43.54%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe CAMP4 Therapeutics is more favorable than Comtech Telecommunications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CAMP4 Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Comtech Telecommunications	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, CAMP4 Therapeutics had 2 more articles in the media than Comtech Telecommunications. MarketBeat recorded 4 mentions for CAMP4 Therapeutics and 2 mentions for Comtech Telecommunications. Comtech Telecommunications' average media sentiment score of 1.43 beat CAMP4 Therapeutics' score of 0.15 indicating that Comtech Telecommunications is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CAMP4 Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Comtech Telecommunications	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CAMP4 Therapeutics has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market. Comparatively, Comtech Telecommunications has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Summary

CAMP4 Therapeutics and Comtech Telecommunications tied by winning 7 of the 14 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to KVH Industries?

KVH Industries (NASDAQ:KVHI) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

KVH Industries has higher revenue and earnings than CAMP4 Therapeutics. KVH Industries is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KVH Industries	$111.01M	1.32	-$7.38M	-$0.26	N/A
CAMP4 Therapeutics	$3.50M	59.50	-$80.40M	-$2.36	N/A

73.7% of KVH Industries shares are held by institutional investors. 21.4% of KVH Industries shares are held by company insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

KVH Industries has a net margin of -4.31% compared to CAMP4 Therapeutics' net margin of -2,193.72%. KVH Industries' return on equity of -0.80% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KVH Industries	-4.31%	-0.80%	-0.70%
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%

In the previous week, CAMP4 Therapeutics had 1 more articles in the media than KVH Industries. MarketBeat recorded 4 mentions for CAMP4 Therapeutics and 3 mentions for KVH Industries. KVH Industries' average media sentiment score of 0.87 beat CAMP4 Therapeutics' score of 0.15 indicating that KVH Industries is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KVH Industries	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CAMP4 Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

KVH Industries has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.08, suggesting that its stock price is 92% less volatile than the broader market.

CAMP4 Therapeutics has a consensus target price of $8.60, suggesting a potential upside of 114.46%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than KVH Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KVH Industries	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CAMP4 Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

KVH Industries beats CAMP4 Therapeutics on 9 of the 16 factors compared between the two stocks.

Get CAMP4 Therapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CAMP vs. The Competition

Export

Metric	CAMP4 Therapeutics	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$212.38M	$3.30B	$6.64B	$12.06B
Dividend Yield	N/A	2.33%	2.67%	5.55%
P/E Ratio	-1.70	18.68	24.75	23.76
Price / Sales	59.50	297.55	508.64	105.22
Price / Cash	N/A	118.24	42.36	56.09
Price / Book	3.93	8.06	10.47	6.72
Net Income	-$80.40M	$23.83M	$3.56B	$337.35M
7 Day Performance	0.75%	-2.82%	-1.11%	-2.54%
1 Month Performance	-10.09%	2.22%	1.28%	1.42%
1 Year Performance	123.40%	37.70%	21.20%	24.71%

CAMP4 Therapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CAMP CAMP4 Therapeutics	2.2892 of 5 stars	$4.01 -2.0%	$8.60 +114.5%	+111.9%	$212.38M	$3.50M	N/A	644	Positive News
NTGR NETGEAR	2.3306 of 5 stars	$27.25 +2.0%	$36.00 +32.1%	-16.6%	$716.89M	$699.62M	N/A	690
RBBN Ribbon Communications	4.3723 of 5 stars	$3.34 +8.1%	$3.58 +7.2%	-22.0%	$544.27M	$825.88M	19.65	3,080	News Coverage
AVNW Aviat Networks	4.4791 of 5 stars	$18.12 +1.9%	$30.00 +65.6%	-14.4%	$230.19M	$434.61M	26.26	710	Analyst Revision
CMTL Comtech Telecommunications	1.9814 of 5 stars	$5.80 +1.4%	$6.00 +3.4%	+97.8%	$172.46M	$474.95M	N/A	1,385

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CAMP) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CAMP4 Therapeutics (CAMP) Competitors

CAMP vs. NTGR, RBBN, AVNW, CMTL, and KVHI

How does CAMP4 Therapeutics compare to NETGEAR?

Summary

How does CAMP4 Therapeutics compare to Ribbon Communications?

Summary

How does CAMP4 Therapeutics compare to Aviat Networks?

Summary

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

Summary

How does CAMP4 Therapeutics compare to KVH Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CAMP vs. The Competition

CAMP4 Therapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CAMP4 Therapeutics (CAMP) Competitors

CAMP vs. NTGR, RBBN, AVNW, CMTL, and KVHI

How does CAMP4 Therapeutics compare to NETGEAR?

Which has stronger earnings & valuation, NTGR or CAMP?

Do analysts prefer NTGR or CAMP?

Is NTGR or CAMP more profitable?

Do insiders & institutionals hold more shares of NTGR or CAMP?

Which has more risk and volatility, NTGR or CAMP?

Does the media favor NTGR or CAMP?

Summary

How does CAMP4 Therapeutics compare to Ribbon Communications?

Which has preferable valuation & earnings, CAMP or RBBN?

Which has more risk & volatility, CAMP or RBBN?

Does the media prefer CAMP or RBBN?

Do analysts prefer CAMP or RBBN?

Do insiders and institutionals have more ownership in CAMP or RBBN?

Is CAMP or RBBN more profitable?

Summary

How does CAMP4 Therapeutics compare to Aviat Networks?

Which has higher valuation & earnings, AVNW or CAMP?

Is AVNW or CAMP more profitable?

Do insiders & institutionals have more ownership in AVNW or CAMP?

Do analysts prefer AVNW or CAMP?

Does the media favor AVNW or CAMP?

Which has more risk and volatility, AVNW or CAMP?

Summary

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

Which has better valuation and earnings, CAMP or CMTL?

Is CAMP or CMTL more profitable?

Do analysts recommend CAMP or CMTL?

Does the media refer more to CAMP or CMTL?

Which has more risk and volatility, CAMP or CMTL?

Summary

How does CAMP4 Therapeutics compare to KVH Industries?

Which has higher valuation and earnings, KVHI or CAMP?

Do institutionals and insiders have more ownership in KVHI or CAMP?

Is KVHI or CAMP more profitable?

Does the media prefer KVHI or CAMP?

Which has more risk & volatility, KVHI or CAMP?

Do analysts prefer KVHI or CAMP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CAMP vs. The Competition

CAMP4 Therapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools